PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p ...
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p ...
Recently approved safeguard proceeding yielding productive creditor and investor discussions aimed at strengthening Mauna Kea’s long-term financial position Currently in exclusive negotiations phase ...
PARIS & BOSTON--(BUSINESS WIRE)-- Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio ®, the multidisciplinary probe and needle-based confocal laser endomicroscopy ...
Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces that it has ...
Integrating Cellvizio® into TaeWoong’s portfolio of therapeutic devices to create the first fully integrated "imaging-to-therapy" solution for EUS-guided pancreatic care LOS ANGELES & PARIS & BOSTON, ...
MAUNA KEA, Hawaii (Island News) -- In an effort to safeguard and enhance the nesting habitat of the endangered native seabird, ʻuaʻu, the Department of Hawaiian Home Lands (DHHL) announced the ...
MAUNA KEA, Hawai‘i (Island News) -- The Office of Hawaiian Affairs (OHA) decided to drop the lawsuits regarding the oversight of Mauna Kea. The litigation against the state, the Board of Land and ...
Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today reported its financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback